Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134795480> ?p ?o ?g. }
- W2134795480 endingPage "7" @default.
- W2134795480 startingPage "861" @default.
- W2134795480 abstract "Primarily through in vitro studies, the Rho-family of small GTPases and their effector proteins have been implicated in mediating oncogenic properties of cancer cells. We sought to determine if pharmacological inhibition of the RhoA effector proteins known as Rho-kinases (ROCK) with the small molecule inhibitor Y-27632 could inhibit melanoma in vitro and in vivo. We demonstrate that Y-27632 treatment of a panel of melanoma cells alters cellular morphology leading to spindly cells with decreased lamellipodia and increased filopodia formation. Y-27632 treatment decreases invasion and alters cell survival of cultured melanoma cells. IP injection of Y-27632 in tumor-bearing mice resulted in a reduction in melanoma tumor volume compared to control treated mice. These findings suggest that ROCK inhibition can reduce melanoma tumorigenicity." @default.
- W2134795480 created "2016-06-24" @default.
- W2134795480 creator A5001798969 @default.
- W2134795480 creator A5010026549 @default.
- W2134795480 creator A5012695898 @default.
- W2134795480 creator A5014376951 @default.
- W2134795480 creator A5018732938 @default.
- W2134795480 creator A5020245678 @default.
- W2134795480 creator A5037848781 @default.
- W2134795480 creator A5046992729 @default.
- W2134795480 creator A5049925948 @default.
- W2134795480 creator A5051799727 @default.
- W2134795480 creator A5052864631 @default.
- W2134795480 creator A5056784804 @default.
- W2134795480 creator A5059004547 @default.
- W2134795480 creator A5063284089 @default.
- W2134795480 creator A5065818307 @default.
- W2134795480 creator A5069759616 @default.
- W2134795480 creator A5073840455 @default.
- W2134795480 creator A5074649823 @default.
- W2134795480 creator A5078916422 @default.
- W2134795480 creator A5086487972 @default.
- W2134795480 date "2010-03-01" @default.
- W2134795480 modified "2023-10-02" @default.
- W2134795480 title "Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth." @default.
- W2134795480 cites W1521040509 @default.
- W2134795480 cites W1553592685 @default.
- W2134795480 cites W1621440205 @default.
- W2134795480 cites W2001315403 @default.
- W2134795480 cites W2004921564 @default.
- W2134795480 cites W2039909286 @default.
- W2134795480 cites W2046966521 @default.
- W2134795480 cites W2061767895 @default.
- W2134795480 cites W2068320944 @default.
- W2134795480 cites W2074349105 @default.
- W2134795480 cites W2077221186 @default.
- W2134795480 cites W2077979328 @default.
- W2134795480 cites W2083054776 @default.
- W2134795480 cites W2083451010 @default.
- W2134795480 cites W2093969600 @default.
- W2134795480 cites W2095013780 @default.
- W2134795480 cites W2099887793 @default.
- W2134795480 cites W2116007831 @default.
- W2134795480 cites W2126316177 @default.
- W2134795480 cites W2126432370 @default.
- W2134795480 cites W2128523698 @default.
- W2134795480 cites W2130200732 @default.
- W2134795480 cites W2146473598 @default.
- W2134795480 cites W2156121832 @default.
- W2134795480 cites W2168868603 @default.
- W2134795480 cites W2314840414 @default.
- W2134795480 cites W43897445 @default.
- W2134795480 cites W1837150540 @default.
- W2134795480 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20127030" @default.
- W2134795480 hasPublicationYear "2010" @default.
- W2134795480 type Work @default.
- W2134795480 sameAs 2134795480 @default.
- W2134795480 citedByCount "32" @default.
- W2134795480 countsByYear W21347954802012 @default.
- W2134795480 countsByYear W21347954802013 @default.
- W2134795480 countsByYear W21347954802014 @default.
- W2134795480 countsByYear W21347954802015 @default.
- W2134795480 countsByYear W21347954802016 @default.
- W2134795480 countsByYear W21347954802017 @default.
- W2134795480 countsByYear W21347954802019 @default.
- W2134795480 countsByYear W21347954802020 @default.
- W2134795480 countsByYear W21347954802021 @default.
- W2134795480 countsByYear W21347954802022 @default.
- W2134795480 countsByYear W21347954802023 @default.
- W2134795480 crossrefType "journal-article" @default.
- W2134795480 hasAuthorship W2134795480A5001798969 @default.
- W2134795480 hasAuthorship W2134795480A5010026549 @default.
- W2134795480 hasAuthorship W2134795480A5012695898 @default.
- W2134795480 hasAuthorship W2134795480A5014376951 @default.
- W2134795480 hasAuthorship W2134795480A5018732938 @default.
- W2134795480 hasAuthorship W2134795480A5020245678 @default.
- W2134795480 hasAuthorship W2134795480A5037848781 @default.
- W2134795480 hasAuthorship W2134795480A5046992729 @default.
- W2134795480 hasAuthorship W2134795480A5049925948 @default.
- W2134795480 hasAuthorship W2134795480A5051799727 @default.
- W2134795480 hasAuthorship W2134795480A5052864631 @default.
- W2134795480 hasAuthorship W2134795480A5056784804 @default.
- W2134795480 hasAuthorship W2134795480A5059004547 @default.
- W2134795480 hasAuthorship W2134795480A5063284089 @default.
- W2134795480 hasAuthorship W2134795480A5065818307 @default.
- W2134795480 hasAuthorship W2134795480A5069759616 @default.
- W2134795480 hasAuthorship W2134795480A5073840455 @default.
- W2134795480 hasAuthorship W2134795480A5074649823 @default.
- W2134795480 hasAuthorship W2134795480A5078916422 @default.
- W2134795480 hasAuthorship W2134795480A5086487972 @default.
- W2134795480 hasConcept C109185818 @default.
- W2134795480 hasConcept C121608353 @default.
- W2134795480 hasConcept C125705527 @default.
- W2134795480 hasConcept C137738243 @default.
- W2134795480 hasConcept C1491633281 @default.
- W2134795480 hasConcept C184235292 @default.
- W2134795480 hasConcept C201800478 @default.
- W2134795480 hasConcept C2777093181 @default.